Par, Reliant Settle ANDA Suit Over Generic Rythmol
Par Pharmaceutical Inc. and Reliant Pharmaceuticals Inc. have settled patent litigation over Par's efforts to make a generic version of the heart arrhythmia treatment Rythmol SR....To view the full article, register now.
Already a subscriber? Click here to view full article